Shareholder Alert: Ademi LLP investigates whether Flexion Therapeutics, Inc. has obtained a Fair Price in its transaction with Pacira

MILWAUKEE, Oct. 11, 2021 /PRNewswire/ -- Ademi LLP is investigating Flexion (Nasdaq: FLXN), for possible breaches of fiduciary duty and other violations of law in its transaction with Pacira.

Click here to learn how to join the action: https://www.ademilaw.com/case/flexion-therapeutics-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.